MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/biomedicines13071704

Медицинская библиотека · Biomedicines · 2025

Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment Initiation.

Moschopoulos Charalampos D, Stanitsa Evangelia, Protopapas Konstantinos, Vatsi Akrivi, Galani Irene, Zetterberg Henrik, Beratis Ion, Fragkou Paraskevi C, Tsiodras Sotirios, Kavatha Dimitra, Papadopoulos Antonios, Papageorgiou Sokratis G, Antoniadou Anastasia

СтатьяПеревод в очереди

Аннотация

Introduction

Human immunodeficiency virus (HIV)-associated neurocognitive impairment (NCI) remains a concern despite combination antiretroviral therapy (cART), with cognitive problems often persisting even after viral suppression. The mechanisms underlying neurocognitive deterioration in people living with HIV (PLWH) and the role of plasma biomarkers remain unclear. This study aims to evaluate neurocognitive trajectories and biomarker changes in a real-world cohort of newly diagnosed PLWH initiating cART in Greece.

Methods

This prospective, single-center study assessed neuropsychological performance and plasma biomarkers in treatment-naïve PLWH at baseline and 18 months after cART initiation. HIV-associated neurocognitive disorder (HAND) was classified using the Frascati criteria, and plasma biomarkers of inflammation and monocyte activation were measured. Correlations between biomarkers and cognitive performance were analyzed.

Results

A total of 39 treatment-naïve PLWH were enrolled in this study. At baseline, 45.7% of participants met criteria for HAND, predominantly, asymptomatic neurocognitive impairment (ANI). Over 18 months, neurocognitive function improved, particularly in speed of information processing, executive function, and visuospatial ability, while verbal fluency, fine motor dexterity, and attention/working memory remained unchanged. Biomarkers of inflammation and monocyte activation decreased following cART, except for neopterin, which increased (10.6 vs. 13 ng/mL, p = 0.002), and plasma NFL (7.5 vs. 7.2 pg/mL, p = 0.54), which remained stable. A negative correlation between monocyte activation markers and cognitive performance was observed only at follow-up, suggesting that systemic inflammation may mask these associations in untreated PLWH.

Conclusions

Early cART initiation supports neurocognitive recovery and reduces immune activation in PLWH. The observed correlation between cognitive performance and monocyte activation markers after viral suppression highlights the potential utility of plasma biomarkers in predicting cognitive impairment.

Для цитирования: Moschopoulos Charalampos D, Stanitsa Evangelia, Protopapas Konstantinos, Vatsi Akrivi, Galani Irene, Zetterberg Henrik, Beratis Ion, Fragkou Paraskevi C, Tsiodras Sotirios, Kavatha Dimitra, Papadopoulos Antonios, Papageorgiou Sokratis G, Antoniadou Anastasia. Prospective Neuropsychological and Plasma Biomarker Changes in Treatment-Naïve People Living with HIV After Antiretroviral Treatment Initiation.. Biomedicines. 2025. DOI: 10.3390/biomedicines13071704.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.